News from REMEDY

Researchers have developed new classification criteria for hand osteoarthritis with the support of the European Alliance of Associations for Rheumatology (EULAR). The new criteria combine self-reported data with radiological findings and represent a significant advance for all research within hand osteoarthritis.

In this webinar, you will learn about factors and patient experiences of importance for pain and physical function after total knee replacement. 

In a recently published study in Osteoarthritis and Cartilage, researchers from the Nor-Hand study at the REMEDY center and Diakonhjemmet hospital have uncovered five distinct groups of patients with hand osteoarthritis. The various groups differ from each other in relation to how much pain they experience.

What is the best course of treatment for the inflammatory disease arthritis - rheumatoid arthritis (RA)? With modern treatment, around two out of three people with RA avoid impaired functional capacity. But can the treatment have a price? A recently published research article in The Lancet Rheumatology provides new insights into different treatment strategies.

Diakonhjemmet hospital is among the six hospitals that do the most research in Norway. Many of the studies are clinical research.

Let's get LinkedIn up and running for the REMEDY Center!

The driver to increase in size and reach is people liking and sharing. If you have the opportunity to click into LinkedIn, you can share the matter in English. There is also a Norwegian version that can be shared.

The health sector is responsible for large greenhouse gas emissions. Now two leading research environments in Norway are taking an international initiative to calculate the climate footprint in advance of medical treatments. The goal is to offer healthcare services that are best for both the patient and the planet. These ambitions have recently been published in the highest ranked medical journal internationally, The New England Journal of Medicine ^[1]. 

The doctoral work shows a connection between the patient's immune response and treatment effect in inflammatory diseases of the joints and intestines. The research has contributed to greater understanding of how the immune system affects the effect of biological medicines and COVID-19 vaccines in people with such diseases.

Join the MAGIC Evidence Ecosystem Foundation for the Conference on Evidence-Based Medicine and AI to explore the implications for healthcare policy and practice in Norway.

- We are thrilled to invite you to register for an exciting and insightful conference exploring the synergy between Evidence-Based Medicine (EBM) and Artificial Intelligence (AI), focusing on the implications for healthcare policy and practice in Norway, says Per Olav Vandvik, CEO of MAGIC.